ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

University of California San Diego at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

University of California San Diego takes part in 12 sessions at ESMO 2026 in Madrid. Its program covers treatment and biomarkers across prostate, endometrial and other cancers. It examines treatments for prostate cancer that has spread despite hormone therapy, including a T-cell-engaging drug and combinations with other medicines.

OrganizationESMO 2026 Attendance
University & institute
Public research university in La Jolla, San Diego, California, with a school of medicine and a cancer centre.
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Multiomic model to predict response to lenvatinib in HCC
ePoster session 23
Gastrointestinal cancersBiomarkers & precision oncology
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
PRISM: Phase 1b of retifanlimab and ruxolitinib in solid malignancies progressing on prior checkpoint inhibition
ePoster session 19
Genitourinary cancersLung & thoracic cancers
Talk
Fri Oct 23
13:50–14:10
First-line systemic therapy of patients with metastatic or recurrent EC (dMMR and non- dMMR)
Update on the mangement of endometrial cancer in the era of molecular classification
Gynaecological cancers
Satellite
Sat Oct 24
13:15–13:20
Audience polling
GSK - From Discovery to Impact: ADCs in Endometrial and Ovarian Cancer Care · with Hospital Universitario Puerta de Hierro Majadahonda, Centre Léon Bérard
Gynaecological cancers
Satellite
Sat Oct 24
13:20–13:35
Spotlight on Advanced/Recurrent EC: An In-Depth Exploration of ADCs in Development
GSK - From Discovery to Impact: ADCs in Endometrial and Ovarian Cancer Care
Gynaecological cancers
Chair
Sun Oct 25
08:30–10:00
Satellite
Sun Oct 25
13:05–13:15
Building Bridges in the Management of CSCC
Regeneron - Reshaping Adjuvant and Perioperative Strategies in CSCC: Integrating Surgery, Radiation, and Systemic Therapies Through Multidisciplinary Decisions · with George Washington University, Gustave Roussy, Policlinico Universitario Agostino Gemelli +1 more
Melanoma & skin cancers
Satellite
Sun Oct 25
13:05–13:35
Deep Dive: The Pivotal Evidence Base in mHSPC
Medscape Global Oncology - Navigating the New Era of mHSPC and nmCRPC: Data-Driven Strategies for Therapy Selection
Genitourinary cancers
Satellite
Sun Oct 25
13:15–13:35
Resectable or Not: Navigating the Gray Zones in Advanced CSCC
Regeneron - Reshaping Adjuvant and Perioperative Strategies in CSCC: Integrating Surgery, Radiation, and Systemic Therapies Through Multidisciplinary Decisions · with George Washington University, Gustave Roussy, Policlinico Universitario Agostino Gemelli +1 more
Melanoma & skin cancers
Satellite
Sun Oct 25
13:35–13:50
Defining High-risk CSCC: Identifying Patients Who Need More
Regeneron - Reshaping Adjuvant and Perioperative Strategies in CSCC: Integrating Surgery, Radiation, and Systemic Therapies Through Multidisciplinary Decisions · with George Washington University, Gustave Roussy, Policlinico Universitario Agostino Gemelli +1 more
Melanoma & skin cancers
Satellite
Sun Oct 25
13:50–14:20
Timing and Selection of Systemic Therapy in Resectable CSCC
Regeneron - Reshaping Adjuvant and Perioperative Strategies in CSCC: Integrating Surgery, Radiation, and Systemic Therapies Through Multidisciplinary Decisions · with George Washington University, Gustave Roussy, Policlinico Universitario Agostino Gemelli +1 more
Melanoma & skin cancers
Satellite
Sun Oct 25
13:55–14:25
Expert Quickfire on Clinical Decision-Making: From Data to Practice in mHSPC and nmCRPC
Medscape Global Oncology - Navigating the New Era of mHSPC and nmCRPC: Data-Driven Strategies for Therapy Selection · with University Medical Center Freiburg, Dana-Farber Cancer Institute
Genitourinary cancers
Satellite
Sun Oct 25
14:20–14:30
Audience Q&A
Regeneron - Reshaping Adjuvant and Perioperative Strategies in CSCC: Integrating Surgery, Radiation, and Systemic Therapies Through Multidisciplinary Decisions · with George Washington University, Gustave Roussy, Policlinico Universitario Agostino Gemelli +1 more
Melanoma & skin cancers
Satellite
Sun Oct 25
19:00–19:25
Advancing to Other Tumours: Trop 2 Directed ADCs in Endometrial Cancer
Gilead and Kite Oncology - The ADC Evolution in Breast and Gynaecologic Cancers: Foundation, Advancement, Future Directions
Breast cancerGynaecological cancers
Satellite
Sun Oct 25
19:45–20:00
Connecting Experience, Potential, and Future Frontiers: Panel discussion and audience Q&A
Gilead and Kite Oncology - The ADC Evolution in Breast and Gynaecologic Cancers: Foundation, Advancement, Future Directions · with Latin American Cooperative Oncology Group, University Hospitals Leuven
Breast cancerGynaecological cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at University of California San Diego

Tell us what you sell and we’ll find the people at University of California San Diego most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction